Related by context. Frequent words. (Click for all words.) 58 squalamine 57 Eligard R 57 Panzem R 57 Wyeth Pharmaceuticals Wyeth 56 deforolimus 56 HCV protease inhibitor 56 RGB # 55 teduglutide 55 anticancer compound 55 Phase IIa clinical trials 55 Bicifadine 54 history Progression 54 MAXY G# 54 investigational compounds 54 Icatibant 54 unique PER.C6 ® 54 Veronate 54 MOR# 54 registrational 54 elotuzumab 53 regadenoson 53 L Annamycin 53 ViiV Healthcare 53 MEK inhibitor 53 Amigal 53 PEGylation technology 53 Cobalamin 52 drug conjugate ADC 52 vilazodone 52 hepatitis C HCV 52 Azedra 52 atacicept 52 GlaxoSmithKline Bristol Myers 52 registrational trial 52 epothilone 52 Hybridon 52 Vilazodone 52 ALN VSP 51 OMJPI 51 phase IIb clinical 51 Diamyd ® 51 Hepatitis C Virus HCV 51 PRX # 51 outlicensing 51 goserelin 51 KNS # 51 QuatRx 51 Medtronic Novartis Biogen 51 tiered royalties 51 TOCOSOL Paclitaxel 51 HuCAL 51 ridaforolimus 51 Mipomersen 51 HIV protease inhibitor 51 manufactures Cialis 51 therapeutic monoclonal antibodies 50 FoldRx 50 HUYA 50 HIV integrase 50 Onalta 50 liposomal formulation 50 alagebrium 50 Captisol 50 BioInvent 50 drug conjugates 50 HGS ETR1 50 rNAPc2 50 cancer immunotherapies 50 preclinical compounds 50 humanized monoclonal antibody 50 Desmoteplase 50 methylnaltrexone 50 Regado 49 CoFactor 49 Versartis 49 chronic HCV infection 49 Nasulin 49 polymerase inhibitors 49 unpartnered 49 Phase 2b clinical 49 ALN TTR# 49 Pervasis 49 betrixaban 49 BCX# 49 GLPG# 49 Zalbin 49 Zolinza 49 Addrenex 49 VEGF Trap 49 sapacitabine 49 Urocidin 49 Exploit collaboration 49 RNAi therapeutic 49 celgosivir 49 anticancer compounds 49 bremelanotide 48 immunotherapeutics 48 kinase inhibitor 48 drug conjugate 48 peptide therapeutics 48 sublicensees